JONATHAN G. DRACHMAN - 03 Jun 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Role: President and CEO, Director
Signature: /s/ Kris McGrew, as Attorney-in-Fact for Jonathan Drachman
Issuer symbol: NGNE
Transactions as of: 03 Jun 2021
Net transactions value: +$475,354
Form type: 4
Filing time: 07 Jun 2021, 17:06:19 UTC
Previous filing: 14 May 2021
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NLTX	Common Stock	Purchase	$379,272	+40,000	+1.8%	$9.48^*	2,238,686	03 Jun 2021	Direct	F1
transaction	NLTX	Common Stock	Purchase	$96,082	+10,000	+0.45%	$9.61^*	2,248,686	04 Jun 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.38 and the highest price at which shares were purchased was $9.51. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2	Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.56 and the highest price at which shares were purchased was $9.62.

Content

Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.38 and the highest price at which shares were purchased was $9.51. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Represents the weighted average purchase price. The lowest price at which shares were purchased was $9.56 and the highest price at which shares were purchased was $9.62.